Joël Ménard
Active 1968–2020
- Also published as
- Joel Menard
- 77
- Papers
- 18,419
- Citations
- 70
- h-index
- 76
- i10-index
Citations
Citation sources
Countries
Institutions
- Inserm1.4%
- Harvard University0.8%
- University College London0.6%
- Université Paris Cité0.5%
- Brigham and Women's Hospital0.5%
- University of Michigan0.4%
- Other95.8%
Fields
- Medicine75.9%
- Neuroscience10.6%
- Biochemistry, Genetics and Molecular Biology6.4%
- Health Professions1.5%
- Nursing0.8%
- Psychology0.6%
- Other4.2%
Topics
- Blood Pressure and Hypertension Studies7.8%
- Hormonal Regulation and Hypertension5.8%
- Renin-Angiotensin System Studies5.2%
- Alzheimer's disease research and treatments3.2%
- Cerebrospinal fluid and hydrocephalus2.8%
- Sodium Intake and Health2.2%
- Other73%
Coauthors
- Pierre Corvol21
- Gilles Châtellier15
- Michel Azizi12
- C Devaux5
- Stevo Julius5
- Alberto Zanchetti4
- F. X. Galen4
- François Alhenc‐Gelas4
- J Bouhnik4
- Lennart Hansson4
- Patrick Bruneval4
- Pierre‐François Plouin4
- T T Guyenne4
- C Devriès3
- Duncan J. Campbell3
- Friedrich C. Luft3
- Giuseppe Mancia3
- I Gyárfás3
- Jean‐Paul Clozel3
- John Chalmers3
- Jürgen Bohlender3
- Michel E. Safar3
- Michel Marre3
- Murielle M. Véniant3
All papers
- Clearance systems in the brain—implications for Alzheimer disease
Authors: Jenna M. Tarasoff-Conway, Roxana O. Carare, Ricardo S. Osorio, Lidia Glodzik, Tracy Butler, Els Fieremans, Leon Axel, Henry Rusinek, Charles Nicholson, Berislav V. Zloković, Blas Frangione, Kaj Blennow, Joël Ménard, Henrik Zetterberg, Thomas Wısnıewskı, Mony J. de Leon - Nature Reviews Neurology 2015 cited by 1,668
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Authors: Lennart Hansson, Alberto Zanchetti, S. George Carruthers, Björn Dahlöf, Dag Elmfeldt, Stevo Julius, Joël Ménard, K. H. Rahn, Hans Wedel, S. Westerling - The Lancet 1998 cited by 5,781
- Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension
Authors: David A. Calhoun, William B. White, Henry Krum, Weinong Guo, Georgina Bermann, Angelo J. Trapani, Martin Lefkowitz, Joël Ménard - Circulation 2011 cited by 213
- A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
Authors: Hari Parthasarathy, Joël Ménard, William B. White, William F. Young, Gordon H. Williams, Bryan Williams, Luís M. Ruilope, Gordon T. McInnes, John Connell, Thomas M. MacDonald - Journal of Hypertension 2011 cited by 278
- Aldosterone Synthase Inhibition With LCI699
Authors: Laurence Amar, Michel Azizi, Joël Ménard, Séverine Peyrard, Catherine E. Watson, Pierre‐François Plouin - Hypertension 2010 cited by 195
- Serial left ventricular adaptations in world-class professional cyclists
Authors: Éric Abergel, Gilles Châtellier, Albert Hagège, Agnes Oblak, Aleš Linhart, Alain Ducardonnet, Joël Ménard - Journal of the American College of Cardiology 2004 cited by 253
- Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension
Authors: Paul E. Verweij, Parisa Danaietash, Bruno Flamion, Joël Ménard, M Bellet - Hypertension 2020 cited by 90
- Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension
Authors: F. Trensz, Céline Bortolamiol, Markus Kramberg, Daniel Wanner, Hakim Hadana, Markus Rey, Daniel S. Strasser, Stéphane Delahaye, Patrick Hess, Enrico Vezzali, Ulrich Mentzel, Joël Ménard, Martine Clozel, Marc Iglarz - Journal of Pharmacology and Experimental Therapeutics 2019 cited by 58
- Aldosterone synthase inhibition in humans
Authors: Michel Azizi, Laurence Amar, Joël Ménard - Nephrology Dialysis Transplantation 2012 cited by 98
- Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement
Authors: Duncan J. Campbell, Juerg Nussberger, Michael Stowasser, A.H. Jan Danser, Alberto Morganti, Erik Frandsen, Joël Ménard - Clinical Chemistry 2009 cited by 187
- Unemployment is associated with high cardiovascular event rate and increased all-cause mortality in middle-aged socially privileged individuals
Authors: Pierre Meneton, Emmanuelle Kesse‐Guyot, Caroline Méjean, Léopold Fezeu, Pilar Galán, Serge Herçberg, Joël Ménard - International Archives of Occupational and Environmental Health 2014 cited by 96
- Trends in Worldwide Research in Hypertension Over the Period 1999–2018
Authors: Patrick Devos, Joël Ménard - Hypertension 2020 cited by 65
- Efficacy and tolerance of spironolactone in essential hypertension
Authors: Xavier Jeunemaı̂tre, Gilles Châtellier, C. Kreft-Jaïs, Anne Charru, C Devriès, Pierre‐François Plouin, Pierre Corvol, Joël Ménard - The American Journal of Cardiology 1987 cited by 271
- Reproducibility of the 6-minute Walk Test in Obese Adults
Authors: K. Beriault, André C. Carpentier, Claudia Gagnon, Joël Ménard, Jean‐Patrice Baillargeon, Jean‐Luc Ardilouze, Marie‐France Langlois - International Journal of Sports Medicine 2009 cited by 162
- Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects
Authors: Patrick Rossignol, Joël Ménard, Renaud Fay, Finn Gustafsson, Bertram Pitt, Faı̈ez Zannad - Journal of the American College of Cardiology 2011 cited by 123
- Bibliometric analysis of research relating to hypertension reported over the period 1997–2016
Authors: Patrick Devos, Joël Ménard - Journal of Hypertension 2019 cited by 94
- Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.
Authors: Michel Azizi, A Rousseau, Éric Ezan, T T Guyene, Stéphanie Michelet, J M Grognet, M. Lenfant, Pierre Corvol, Joël Ménard - Journal of Clinical Investigation 1996 cited by 339
- Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
Authors: Michel Marre, Michel Lièvre, Gilles Châtellier, Johannes F.E. Mann, P Passa, Joël Ménard - BMJ 2004 cited by 292
- Masked hypertension: a systematic review
Authors: Guillaume Bobrie, Pierre Clerson, Joël Ménard, Nicolas Postel‐Vinay, Gilles Châtellier, Pierre‐François Plouin - Journal of Hypertension 2008 cited by 265
- The 45-year story of the development of an anti-aldosterone more specific than spironolactone
Authors: Joël Ménard - Molecular and Cellular Endocrinology 2003 cited by 103
- Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
Authors: Michel Marre, Gilles Châtellier, Hélène Leblanc, T T Guyene, Joël Ménard, P Passa - BMJ 1988 cited by 384
- Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.
Authors: Michel Marre, Hélène Leblanc, L Suarez, T T Guyenne, Joël Ménard, P Passa - BMJ 1987 cited by 262
- Antiandrogenic Effect of Spirolactones: Mechanism of Action
Authors: Pierre Corvol, Annie Michaud, Joël Ménard, MARTIN FREIFELD, J Mahoudeau - Endocrinology 1975 cited by 258
- The number needed to treat: a clinically useful nomogram in its proper context
Authors: Gilles Châtellier, Éric Zapletal, D Lemaitre, Joel Menard, Patrice Degoulet - BMJ 1996 cited by 204
